brainQr Therapeutics Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Series AA

  • Investors
  • 2

brainQr Therapeutics General Information

Description

Developer of AI-driven small molecule therapies intended to treat diseases associated with disordered proteins. The company facilitates protein-targeting treatment approaches focused on modulating protein dysfunction, enabling patients and healthcare providers to access therapies for conditions with limited treatment options.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Von-Siebold-Street. 3a
  • 37075 Göttingen
  • Germany
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Corporate Office
  • Von-Siebold-Street. 3a
  • 37075 Göttingen
  • Germany

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

brainQr Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series AA) 01-Aug-2025 Completed Pre-Clinical Trials
1. Accelerator/Incubator Completed Pre-Clinical Trials
To view brainQr Therapeutics’s complete valuation and funding history, request access »

brainQr Therapeutics Patents

brainQr Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202511452-D0 Small molecule modulators of tau proteins Pending 15-Jul-2025

brainQr Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

brainQr Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Life Science Valley Ventures Management Venture Capital Minority
Life Science Factory Accelerator/Incubator
To view brainQr Therapeutics’s complete investors history, request access »

brainQr Therapeutics FAQs

  • When was brainQr Therapeutics founded?

    brainQr Therapeutics was founded in 2024.

  • Where is brainQr Therapeutics headquartered?

    brainQr Therapeutics is headquartered in Göttingen, Germany.

  • What is the size of brainQr Therapeutics?

    brainQr Therapeutics has 5 total employees.

  • What industry is brainQr Therapeutics in?

    brainQr Therapeutics’s primary industry is Biotechnology.

  • Is brainQr Therapeutics a private or public company?

    brainQr Therapeutics is a Private company.

  • What is brainQr Therapeutics’s current revenue?

    The current revenue for brainQr Therapeutics is .

  • Who are brainQr Therapeutics’s investors?

    Life Science Valley Ventures Management and Life Science Factory have invested in brainQr Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process